Mater Research is a recognised leader in medical research. Our bench to bedside philosophy sees us working across Mater Health’s hospitals and health services, The University of Queensland, and the world-class Translational Research Institute (TRI). We are committed to working closely with Mater Health, Mater Education and our growing network of partners and collaborators to turn scientific discovery into the best possible treatment, care, and outcomes for patients and our broader community. 

Our key focus areas are Cancer biology and care , Chronic disease biology and care , Implementing evidence to improve health , Mothers', babies and women's health , Neurosciences and cognitive health , Optimising acute care .

App hopes to reduce stillbirths by 30 per cent
A new mobile phone app being trialled at Mater Mothers’ Hospital Brisbane aims to reduce the rate of stillbirth in Australia by 30 per cent by focusing on a baby’s kicks.
180K to support women changing our world
Two female researchers in Queensland have been awarded strategic grants as a step forward in closing the research and academic gender gap. The 2019 winners of the Mater Research Strategic Grants for Outstanding Women were awarded to Associate Professor Kristen Radford and Dr Sandra Richardson.
Latest News

Mater researcher and Director of the Stillbirth Centre for Research Excellence (CRE) Professor Vicki Flenady has been awarded $1.3 million...

11

Mar

New Federal support to ensure more healthy pregnancies in Australia

Two female researchers in Queensland have been awarded strategic grants as a step forward in closing the research and academic gender gap.

05

Mar

180K to support women changing our world

The International Diabetes Federation 2019 Congress has selected Mater’s Professor David McIntyre to provide the prestigious ‘Stream Award...

04

Mar

Professor David McIntyre selected to present prestigious lecture

Mater Research—University of Queensland (MRI—UQ) Acting Director Professor Maher Gandhi has been awarded $3.6 million to improve treatment for...

18

Feb

$3.6 million awarded to develop treatment for relapsed lymphoma patients

Dr Peter Steer has commenced his appointment as Mater Group Chief Executive Officer.

09

Jan

New Mater Group CEO takes the reins

Mater is proud to officially welcome Professor Patrick Chauvel as Professorial Research Fellow at Mater Research.

12

Nov

Welcome Professor Patrick Chauvel

A devotion to closing the gap in maternity care for Aboriginal and Torres Strait Islander women has seen Professor Sue Kildea awarded the...

09

Nov

Closing the gap in maternity health services

Four Mater clinicians have been successful in receiving research funding from the coveted Betty McGrath Fellowship Scheme.

05

Nov

2018 Betty McGrath Fellowship Scheme recipients announced

A new mobile phone app being trialled at Mater Mothers’ Hospital Brisbane aims to reduce the rate of stillbirth in Australia by 30 per cent by...

01

Nov

App hopes to reduce stillbirths by 30 per cent

A new triple-combination drug trialled at Mater in Brisbane could increase the life expectancy of patients with cystic fibrosis (CF).

19

Oct

Mater helps bring new hope to patients with cystic fibrosis